Litigation Details for ASTRAZENECA PHARMACEUTICALS LP v. AUROBINDO PHARMA LIMITED (D.N.J. 2019)
✉ Email this page to a colleague
ASTRAZENECA PHARMACEUTICALS LP v. AUROBINDO PHARMA LIMITED (D.N.J. 2019)
Docket | ⤷ Sign Up | Date Filed | 2019-05-15 |
Court | District Court, D. New Jersey | Date Terminated | 2020-02-06 |
Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
Jury Demand | None | Referred To | Lois H. Goodman |
Patents | 8,536,206; 8,604,064; 8,618,142 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in ASTRAZENECA PHARMACEUTICALS LP v. AUROBINDO PHARMA LIMITED
Details for ASTRAZENECA PHARMACEUTICALS LP v. AUROBINDO PHARMA LIMITED (D.N.J. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2019-05-15 | 1 | Complaint | of U.S. Patent No. 8,536,206 (“the ’206 Patent”), U.S. Patent No. 8,604,064 (“the ’064 Patent”), and …matter in controversy involves United States Patent Nos. 8,536,206, 8,604,064, and 8,618,142 and the same …and U.S. Patent No. 8,618,142 (“the ’142 Patent) (collectively, “the asserted patents”). 12. …, and ’142 Patents. Count 1: Patent Infringement of the ’206 Patent … This is a civil action for patent infringement arising under the patent laws of the United States, | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |